Dermatology · Hampton, VA
NPI
1073770905
Since 2008
Specialty
Dermatology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2207 Executive Dr Ste A
Hampton, VA, 23666
Phone (757) 838-8525
Groups this clinician bills Medicare through
Medicare paid, 2024
$169K
2,772 services
Medicare patients, 2024
560
Average age 75
Drug cost, 2024
$866K
2,048 prescriptions
Company payments, 2025
$1,974
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Annyce C Treherne was code 99214 (office e&m - established), 502 times for 339 patients. In total Annyce C Treherne billed 2,772 services in 55 codes, and Medicare paid $169K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 502 | 339 | $97.12 | $49K |
| 99213 Office E&M - Established | Office | 448 | 281 | $70.23 | $31K |
| 17003 Destruction Skin Lesion | Office | 438 | 82 | $5.43 | $2,379 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 191 | 51 | $0.70 | $134 |
| 11102 Skin Biopsy | Office | 182 | 145 | $70.19 | $13K |
| 17000 Destruction Skin Lesion | Office | 174 | 129 | $41.96 | $7,302 |
| 11901 Skin | Office | 94 | 28 | $53.53 | $5,032 |
| 17110 Destruction Skin Lesion | Office | 87 | 70 | $89.00 | $7,743 |
| 99215 Office E&M - Established | Office | 72 | 62 | $144.05 | $10K |
| 99203 Office E&M - New | Office | 68 | 68 | $78.81 | $5,359 |
| 11103 Skin Biopsy | Office | 59 | 43 | $40.49 | $2,389 |
| 11900 Skin | Office | 41 | 27 | $38.32 | $1,571 |
| 11104 Skin Biopsy | Office | 40 | 38 | $102.01 | $4,080 |
| 99204 Office E&M - New | Office | 22 | 22 | $131.07 | $2,884 |
| 99212 Office E&M - Established | Office | 20 | 18 | $41.50 | $830 |
By year: 2022 $153K for 2,698 services; 2023 $134K for 2,351 services; 2024 $169K for 2,772 services.
Medicare prescription drug claims, 2024
In 2024, the drug Annyce C Treherne prescribed most often to Medicare patients was Mometasone Furoate, with 219 prescriptions and refills. In total Annyce C Treherne wrote 2,048 Medicare prescriptions that cost $866K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mometasone Furoate Generic | 219 | 236 | 149 | $4,034 |
| Clobetasol Propionate Generic | 164 | 193 | 91 | $8,507 |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 149 | 171 | 69 | $11K |
| Ketoconazole Generic | 145 | 163 | 98 | $3,250 |
| Triamcinolone Acetonide Generic | 119 | 135 | 95 | $1,478 |
| Ciclopirox Generic | 96 | 108 | 56 | $4,506 |
| Clindamycin Phosphate Generic | 92 | 94 | 38 | $2,497 |
| Dupixent Pen Dupilumab | 85 | 85 | Under 11 | $318K |
| Fluocinonide Generic | 78 | 79 | 40 | $3,885 |
| Doxycycline Hyclate Generic | 71 | 96 | 38 | $999 |
| Mupirocin Generic | 70 | 71 | 52 | $660 |
| Metronidazole Generic | 51 | 55 | 25 | $2,902 |
| Tretinoin Generic | 43 | 56 | 24 | $3,852 |
| Betamethasone Valerate Generic | 39 | 39 | 13 | $1,114 |
| Hydroxyzine Hcl Generic | 33 | 39 | Under 11 | $172 |
Brand drugs: 265 claims; generic drugs: 1,783 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Annyce C Treherne $1,974 ($1,974 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $414.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 36 | $414 |
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $327 |
| Janssen Biotech, Inc. JNJ | 13 | $276 |
| Galderma Laboratories, L.P. GALD.SW | 19 | $192 |
| UCB, Inc. UCB.BR | 10 | $171 |
| Arcutis Biotherapeutics, Inc. ARQT | 5 | $138 |
| Incyte Corporation INCY | 5 | $117 |
| Lilly USA, LLC LLY | 4 | $75.9 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $60.69 |
| Pfizer Inc. PFE | 3 | $59.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.